First person – Katie Lloyd and Stamatia Papoutsopoulou

• Published in: Disease models & mechanisms 2020-11, Vol.13 (11)
• Format: Article
• Language: English
• Subjects: Antibiotics; Careers; COVID-19; Drugs; Experiments; First Person; Hypotheses; Immune system; Inflammation; Inflammatory bowel disease; Laboratories; Medical research; Pathogenesis
• ISSN: 1754-8403; 1754-8411
• DOI: 10.1242/dmm.047506

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Katie Lloyd and Stamatia Papoutsopoulou are co-first authors on ‘Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease’, published in DMM. Katie conducted the research described in this article while a postdoctoral research associate in Prof. Chris Probert's lab at the University of Liverpool, Liverpool, UK. She is now a lecturer in pharmacology at the University of Chester, Chester, UK. Her research focuses on personalising medicine by combining innovative experimental approaches to identify biomarkers of inflammatory disease, drug response and mechanisms of drug resistance, which consider complex factors such as inter-patient variability and co-morbidities. Stamatia conducted the research described in this article while a postdoctoral research associate in Werner Muller's lab at the University of Manchester, Manchester, UK. She is currently a postdoctoral research associate in the lab of Mark Pritchard at the University of Liverpool, Liverpool, UK, investigating the regulation of transcriptional responses during inflammation and the impact of environmental factors on them, and has just accepted the position of assistant professor at the University of Thessaly, Greece.